TECNIS IOL ZLU225 (REF ZLU225U155)Recalls & reported problems
Johnson & Johnson Surgical Vision, Inc. · TECNIS TORIC LOW ADD 1-PC 15.5D CYL2.25 · Class 3 · Implant
All models of TECNIS IOL (1344)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05050474689862), received between Jun 6, 2024 and Jul 28, 2025 — classified as 2 injuries.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Appropriate Device Problem Term/Code Not Available1
Patient problems
- Halo2
- Visual Disturbances2
- Discomfort1
- Headache1
- Vitreous Loss1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryJul 28, 2025Appropriate Device Problem Term/Code Not Available; Appropriate Device Problem Term/Code Not Available
THE ZLU225 MODEL INTRAOCULAR LENS (IOL) WAS IMPLANTED IN THE PATIENT¿S OCULAR DEXTER (RIGHT EYE). DUE TO COMPLAINTS OF DECREASE IN VISION, GLARE, HALOES, LIGHT SENSITIVITY, AND A VISUALLY SIGNIFICANT MECHANICAL COMPLICATION, THE PATIENT CONSENTED FOR AN OPERATIVE PROCEDURE AFTER A DISCUSSION OF RISKS AND BENEFITS OF THE SURGERY. THE IOL WAS EXPLANTED IN A SECONDARY SURGICAL PROCEDURE AND REPLACED WITH A DRT300 15.5 IOL. THE LIDS, LASHES, AND CONJUNCTIVA WERE THEN METICULOUSLY PREPARED WITH A 5% BETADINE SOLUTION AND THE EYE WAS THEN IRRIGATED WITH BALANCED SALINE SOLUTION MIXED WITH DILUTE BETADINE. THE PATIENT WAS THEN DRAPED AND A WIRE LID SPECULUM WAS PLACED INTO THE SURGICAL EYE. A TORIC MARKER WAS USED TO MARK 8 DEGREES CLOCKWISE OF THE PRIOR TORIC MARKS, AT APPROXIMATELY 97 DEGREES. A 1.0MM SIDE PORT BLADE WAS USED TO CREATE TWO PARACENTESES. VISCOELASTIC WAS INSTILLED INTO THE ANTERIOR CHAMBER AND BELOW THE LENS AND A 2.5 MM SINGLE BEVEL METAL KERATOME BLADE WAS USED TO MAKE THE INITIAL INCISION. THE INTRAOCULAR LENS WAS DISSECTED FROM THE CAPSULAR BAG USING VISCOELASTIC DEVICE AND DIALED INTO THE ANTERIOR CHAMBER. THE LENS WAS CUT IN THIRDS USING MST MICRO-SCISSORS AND EACH
Patient problems: Halo; Visual Disturbances; Vitreous Loss
MAUDE report 22638366 ↗InjuryJun 6, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE ZLU225 15.5 DIOPTER MODEL INTRAOCULAR LENS (IOL) WAS IMPLANTED INTO THE PATIENT¿S OCULAR SINISTER (LEFT EYE). PATIENT REPORTS COMPLAINTS OF BEING UNHAPPY WITH THE VISION QUALITY. IOL EXPLANT PROCEDURE WAS CANCELLED AND WILL BE RESCHEDULED. THE SUSPECT IOL IS NOT AVAILABLE FOR RETURN AS IT REMAINS IMPLANTED. NO FURTHER INFORMATION IS AVAILABLE. 13-MAY-2024: ADDITIONAL INFORMATION WAS RECEIVED CONFIRMING THE IOL WAS EXPLANTED IN A SECONDARY SURGICAL PROCEDURE DUE TO COMPLAINTS OF SEVERE HEADACHES, HALOS, ¿UNABLE TO READ ANYTHING,¿ DISSATISFIED WITH VISION, AND DECREASED QUALITY OF LIFE. THE EXPLANTED IOL WAS REPLACED WITH A ZCU225 16.5 DIOPTER IOL. THERE WAS NO PRODUCT QUALITY ISSUE THAT CONTRIBUTED TO THE IOL EXPLANT DECISION. THERE WAS NO COMPLICATION, INCISION ENLARGEMENT, SERIOUS INJURY, SUTURES, AND NO VITRECTOMY DURING THE EXPLANT PROCEDURE. PATIENT STATUS POST-LENS EXCHANGE WAS REPORTED AS VISUAL ACUITY: 20/25, WILL CONTINUE TO FOLLOW POST-OPERATIVELY. FOLLOW-UP IN 3-MONTHS WITH DILATED EXAM. NO FURTHER INFORMATION IS AVAILABLE.
Patient problems: Discomfort; Halo; Headache; Visual Disturbances
MAUDE report 19474061 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page